Addressing unmeasured confounding in comparative observational research (original) (raw)
Using the Literature to Identify Confounders
Scott A Malec
EasyChair Preprints, 2018
View PDFchevron_right
Bias amplification of unobserved confounding in pharmacoepidemiological studies using indication-based sampling: there is no free lunch in restricting the sample to those with a particular drug-indication
Daniel Berglind
2022
View PDFchevron_right
Assessing the impact of unmeasured confounders for credible and reliable real‐world evidence
James Stamey
Pharmacoepidemiology and Drug Safety, 2020
View PDFchevron_right
Methodological issues of confounding in analytical epidemiologic studies
Karimollah Hajian-Tilaki
Caspian journal of internal medicine, 2012
View PDFchevron_right
Methods to assess intended effects of drug treatment in observational studies are reviewed
Anthonius Boer
Journal of Clinical Epidemiology, 2004
View PDFchevron_right
Confounder summary scores when comparing the effects of multiple drug exposures
Suzanne Cadarette
Pharmacoepidemiology and Drug Safety, 2010
View PDFchevron_right
Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review
Adolfo Figueiras
BMC Medical Research Methodology, 2019
View PDFchevron_right
Assessment and control for confounding by indication in observational studies
Curt Furberg
1999
View PDFchevron_right
Correction of confounding bias in non-randomized studies by appropriate weighting
Susanne Stampf
Biometrical Journal, 2011
View PDFchevron_right
Using the Literature to Construct Causal Models for Pharmacovigilance
Scott A Malec
EasyChair Preprints, 2018
View PDFchevron_right
Estimating causal log-odds ratio using the case-control sample and its application in the pharmaco-epidemiology study
Anqi Zhu
Statistical methods in medical research, 2018
View PDFchevron_right
Adjustment for missing confounders in studies based on observational databases: 2-stage calibration combining propensity scores from primary and validation data
Yi-Hau Chen
American journal of epidemiology, 2014
View PDFchevron_right
Methodological issues in using prescription and other databases in pharmacoepidemiology
Bente Nørgård
Norsk Epidemiologi, 2009
View PDFchevron_right
Pharmacoepidemiology Studies: what Levels of Evidence and how can They be Reached?
Maryse Lapeyre-mestre
Therapies, 2013
View PDFchevron_right
Causal assessment of pharmaceutical treatments: why standards of evidence should not be the same for benefits and harms
barbara osimani
View PDFchevron_right
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies
Daniel Jakson
Statistics in Medicine, 2009
View PDFchevron_right
STrengthening the Reporting of OBservational studies in Epidemiology���Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement
Cynthia Mulrow
2011
View PDFchevron_right
A proxy outcome approach for causal effect in observational studies: a simulation study
Yuejen Zhao
BioMed research international, 2014
View PDFchevron_right
Evaluation of propensity scores, disease risk scores, and regression in confounder adjustment for the safety of emerging treatment with group sequential monitoring
Bruce Fireman
Pharmacoepidemiology and Drug Safety, 2016
View PDFchevron_right
Addressing Confounders in Retrospective Studies
Joe Ensor
Journal of Vascular and Interventional Radiology, 2017
View PDFchevron_right
Risks and benefits of (pharmaco)epidemiology
Lesley Wise
Therapeutic advances in drug safety, 2011
View PDFchevron_right
The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology
Samantha Lane
Drug Safety, 2021
View PDFchevron_right
Confounders and co-interventions identified in non-randomized studies of interventions
Barnaby Reeves
Journal of Clinical Epidemiology
View PDFchevron_right
Consistency of causal claims in observational studies: a review of papers published in a general medical journal
Els Goetghebeur
BMJ Open, 2021
View PDFchevron_right
Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug Reactions
Carol Friedman
PloS one, 2016
View PDFchevron_right
Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance
Scott A Malec
2020
View PDFchevron_right
Hypothesis-free screening of large administrative databases for unsuspected drug-outcome associations
Jesper Hallas
European Journal of Epidemiology, 2018
View PDFchevron_right
Application of causal inference methods in the analyses of randomised controlled trials: a systematic review
Daphne Kounali
Trials, 2018
View PDFchevron_right
Outcome misclassification: Impact, usual practice in pharmacoepidemiology database studies and an online aid to correct biased estimates of risk ratio or cumulative incidence
Rosa Gini
Pharmacoepidemiology and Drug Safety, 2020
View PDFchevron_right
Regression analysis of unmeasured confounding
Brian Knaeble
Epidemiologic Methods, 2020
View PDFchevron_right
Primary versus secondary source of data in observational studies and heterogeneity in meta-analyses of drug effects: a survey of major medical journals
Fatima Roque
BMC Medical Research Methodology, 2018
View PDFchevron_right
nstrumental variable analysis in randomized trials with non-compliance and observational pharmacoepidemiologic studies
Kit Roes, Anthonius Boer
View PDFchevron_right
History of the modern epidemiological concept of confounding
Alfredo Copa
Journal of Epidemiology and Community Health, 2010
View PDFchevron_right
Control of Confounding and Reporting of Results in Causal Inference Studies: Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
Dominic Fitzgerald
Annals of the American Thoracic Society, 2018
View PDFchevron_right